Celemics, Inc. (KOSDAQ:331920)
11,500
+580 (5.31%)
At close: Jun 29, 2026
Celemics Market Cap
Celemics has a market cap or net worth of 112.67 billion as of June 29, 2026. Its market cap has increased by 321.37% in one year.
Market Cap
112.67B
Enterprise Value
107.17B
Revenue
4.97B
Ranking
n/a
PE Ratio
n/a
Stock Price
11,500.00
Market Cap Chart
Since August 21, 2020, Celemics's market cap has decreased from 200.32B to 112.67B, a decrease of -43.76%. That is a compound annual growth rate of -9.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 112.67B | 408.29% |
| Dec 30, 2025 | 22.17B | -17.10% |
| Dec 30, 2024 | 26.74B | -22.58% |
| Dec 28, 2023 | 34.53B | -27.07% |
| Dec 29, 2022 | 47.35B | -62.21% |
| Dec 30, 2021 | 125.32B | -42.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 21, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curiox Biosystems | 666.63B |
| Biodyne | 258.95B |
| RecensMedical | 172.95B |
| Synergy Innovation | 142.91B |
| M.I.TECH Co.,Ltd | 135.77B |
| BIOBIJOU | 88.31B |
| Corentec | 51.95B |
| DENTIS CO.,Ltd | 39.29B |